Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris

Kardiologia Polska

Volumn 68, Issue 4, 2010, Pages 431-437

  Wudkowska, Anna ^a   Goch, Jan ^b   Goch, Aleksander ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Military Clinical Hospital Bydgoszcz   (Poland)

Author keywords

ACS with no ST elevation; IMA; Unstable angina pectoris

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GLUCOSE; ISCHEMIA MODIFIED ALBUMIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

EID: 77953733284     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Apple FS, Wu AHB, Mair J et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem, 2005; 51: 810-824.
2. Mair J, Morandell D, Genser N et al. Equivalent early sensitivities of myoglobin creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponin I and T for acute myocardial infarction. Clin Chem, 1995; 41: 1266-1272.
3. Figiel Ł, Kasprzak JD, Peruga J et al. Heart-type fatty acid binding protein - a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation. Kardiol Pol, 2008; 66: 253-258.
4. Rembek M, Goch A, Chiżyński K, Goch JH. Ocena klinicznej wiarygodności i diagnostycznej użyteczności oznaczeń h-FABP w ostrych zespołach wieńcowych. Pol Merk Lek, 2006; 125: 418-422.
5. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med, 2000; 19: 311-315.
6. Morrow DA, de Lemos JA, Sabatine MS, Antman EM. The search for a biomarker of cardiac ischemia. Clin Chem, 2003; 49: 537-539.
7. de Filippi C, Yoon S, Ro A. Early detection of myocardial ischemia by a novel blood based biomarker: the kinetics of ischemia modified albumin. J Am Coll Cardiol, 2003; 41: 6 (suppl. A): 340A.
8. Dembińska-Kieć A, Naskalski J. Diagnostyka laboratoryjna z elementami biochemii klinicznej. Elsevier, Urban & Partner, Wrocław 2002.
9. Sinha MK, Gaze DC, Tippins JR et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percu taneous coronary intervention. Circulation, 2003; 107: 2403-2405.
10. Roy D, Quiles J, Sinha M et al. Effects of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am J Cardiol, 2004; 94: 234-236. (Pubitemid 38902880)
11. Roy D, Quiles J, Sinha M et al. Effects of direct - current cardioversion on ischemia-modified albumin levels in patients with arial fibrillation. Am J Cardiol, 2004; 93: 366-368.
12. Wudkowska A, Rebek M, Piechowiak M et al. Wartość oznaczania albuminy modyfikowanej niedokrwieniem w diagnostyce dusznicy bolesnej. Prob Ter Monit, 2009; 20 (in press).
13. Van der Zee PM, Verberne HJ, van Straalen JP et al. Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem, 2005; 51: 1744-1746.
14. Roy D, Quiles J, Aldama G, Sinha M et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiaograms and negative cardiac troponin T. Int J Cardiol, 2004; 97: 297-301.
15. Consuegra-Sanchez L, Bouzas-Mosguera A, Sinha MK et al. Ischemia modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels, 2008; 23:174-180.
16. Worster A, Devereaux PJ, Heels-Ausdell D et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ, 2005; 172: 1685-1690.
17. Gutierrez-Correa J, Stropani AO. Inactivation of yeast glutathione reductase by Fenton systems: effect of metal chelators, catecholamines and thiol compounds. Free Radic Res, 1997; 27: 543-555. (Pubitemid 28053995)
18. Roy D, Quiles J, Gaze DC et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart, 2006; 92: 113-114.
19. Dery M-A, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. IJBCB, 2005; 37: 535-540.
20. Bolli R. The late phase preconditioning. Circ Res 2000; 87: 972-983.
21. Xi L, Tekin D, Gursoy E et al. Evidence that NOS2 act as trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol Heart Circ Physiol, 2002; 283: H5-H12. (Pubitemid 34705317)
22. Xi L, Taher M, Yin C et al. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1α and AP-1 and iNOS signaling. Am J Physiol Heart Circ Physiol, 2004; 287: H2369-H2375.
23. Semeza GL. Targeting HIF-1 for cancer therapy. Nature review. Cancer, 2003; 3: 721-732.
24. Shyu KG, Wang MT, Wang BW et al. Intramyocardial injection of naked DNA encoding HIF-1 alfa/VP16 hydrid to enhance angiogenesis in acute myocardial infarction model in the rat. Cardiovasc Res, 2002; 54: 576-583.
25. Wang TJ, Larson MG, Lewy D et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol, 2002; 90: 254-258.
26. Dominguez-Rodriguez A, Abren-Gonzalez P, Gatcia-Gonzalez MJ et al. Relation of ischemia-modifield albumin levels and left ventricular systolic function in patients with ST- segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Chem Acta, 2008; 388: 196-199.
27. Gaze DC, Crompton L, Collinson PO. Ischemia modified albumin and cardiac troponin in hemodialysis patients. Clin Chem, 2004; 50 (suppl.): A64.
28. Gaze DC, Crompton L, Collinson PO. Ischemia modifield albumin with coution in patients with low serum albumin concentrations. Clin Chem, 2004; 50 (suppl.): A67.